StarsourceMultitrade
New to Zerodha? Sign-up for free.
New to Zerodha? Sign-up for free.
Get instant stock alerts
- Share Price
- Financials
- Revenue mix
- Shareholdings
- Peers
- Forensics
Share Price
Coming soon
- 5D
- 1M
- 6M
- YTD
- 1Y
- 5Y
- MAX
Financials
-
Summary
-
Profit & Loss
-
Balance sheet
-
Cashflow
This data is currently unavailable for this company.
| (In Cr.) |
|---|
| (In Cr.) | ||||
|---|---|---|---|---|
|
This data is currently unavailable for this company. |
| (In %) |
|---|
| (In Cr.) |
|---|
| Financial Year (In Cr.) |
|---|
Revenue mix
-
Product wise
-
Location wise
Revenue Mix
This data is currently unavailable for this company.
Revenue Mix
This data is currently unavailable for this company.
Forensics
Recent events
-
News
-
Corporate Actions
Feb 18 (Reuters) - Chemo Pharma Laboratories Ltd CHEP.BO:
PROMOTERS SIGN SPA WITH ATIBHA AGRISEEDS FOR SHARE TRANSFER
Source text: ID:nBSE4tyV0t
Further company coverage: CHEP.BO
(([email protected];;))
Feb 18 (Reuters) - Chemo Pharma Laboratories Ltd CHEP.BO:
PROMOTERS SIGN SPA WITH ATIBHA AGRISEEDS FOR SHARE TRANSFER
Source text: ID:nBSE4tyV0t
Further company coverage: CHEP.BO
(([email protected];;))
More Nano Cap Ideas
See similar 'Nano' cap companies with recent activity
Promoter Buying
Companies where the promoters are bullish
Capex
Companies investing on expansion
Superstar Investor
Companies where well known investors have invested
Popular questions
- Business
- Financials
- Share Price
- Shareholdings
What does StarsourceMultitrade do?
Chemo Pharma Laboratories Ltd is a company engaged in the manufacture of pharmaceuticals and bulk drugs.
Who are the competitors of StarsourceMultitrade?
StarsourceMultitrade major competitors are Saroja Pharma Inds., Shamrock Indl. Co, Emmessar Biotech&Nut, Beryl Drugs, Ortin Global, Link Pharma Chem, Colinz Laboratories. Market Cap of StarsourceMultitrade is ₹13 Crs. While the median market cap of its peers are ₹13 Crs.
Is StarsourceMultitrade financially stable compared to its competitors?
StarsourceMultitrade seems to be less financially stable compared to its competitors. Altman Z score of StarsourceMultitrade is -5.46 and is ranked 8 out of its 8 competitors.
Does StarsourceMultitrade pay decent dividends?
The company seems to be paying a very low dividend. Investors need to see where the company is allocating its profits. StarsourceMultitrade latest dividend payout ratio is 0% and 3yr average dividend payout ratio is 0%
How has StarsourceMultitrade allocated its funds?
Companies resources are allocated to majorly unproductive assets like Cash & Short Term Investments
How strong is StarsourceMultitrade balance sheet?
StarsourceMultitrade balance sheet is weak and might have solvency issues
Is the profitablity of StarsourceMultitrade improving?
No, profit is decreasing. The profit of StarsourceMultitrade is -₹11.86 Crs for TTM, ₹0.34 Crs for Mar 2025 and ₹1.2 Crs for Mar 2024.
Is the debt of StarsourceMultitrade increasing or decreasing?
Yes, The net debt of StarsourceMultitrade is increasing. Latest net debt of StarsourceMultitrade is -₹0.01 Crs as of Mar-26. This is greater than Mar-25 when it was -₹21.25 Crs.
Is StarsourceMultitrade stock expensive?
StarsourceMultitrade is not expensive. Latest PE of StarsourceMultitrade is 0, while 3 year average PE is 29.99. Also latest EV/EBITDA of StarsourceMultitrade is 0.0 while 3yr average is 1.5.
Has the share price of StarsourceMultitrade grown faster than its competition?
StarsourceMultitrade has given better returns compared to its competitors. StarsourceMultitrade has grown at ~26.42% over the last 2yrs while peers have grown at a median rate of -14.81%
Is the promoter bullish about StarsourceMultitrade?
Promoters stake in the company seems stable, and we need to go through filings and allocation of resources to gauge promoter bullishness. Latest quarter promoter holding in StarsourceMultitrade is 27.89% and last quarter promoter holding is 27.89%.
Are mutual funds buying/selling StarsourceMultitrade?
There is Insufficient data to gauge this.